These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 2339144)

  • 21. The effect of the anorectic agent, d-fenfluramine, and its primary metabolite, d-norfenfluramine, on intact human platelet serotonin uptake and efflux.
    Johnson GJ; Leis LA; Dunlop PC; Weir EK
    J Thromb Haemost; 2003 Dec; 1(12):2663-8. PubMed ID: 14675103
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Differential effects of the isomers of fenfluramine and norfenfluramine on rat striatal acetylcholine content.
    Consolo S; Forloni GL; Garattini S; Ladinsky H; Tirelli AS
    J Pharm Pharmacol; 1979 Oct; 31(10):706. PubMed ID: 41047
    [No Abstract]   [Full Text] [Related]  

  • 23. Decreased accumulation of brain 5-hydroxytryptophan after decarboxylase inhibition in rats treated with fenfluramine, norfenfluramine or p-chloroamphetamine.
    Fuller RW; Perry KW
    J Pharm Pharmacol; 1983 Sep; 35(9):597-8. PubMed ID: 6138413
    [No Abstract]   [Full Text] [Related]  

  • 24. d-Fenfluramine and d-norfenfluramine hypophagias do not require increased hypothalamic 5-hydroxytryptamine release.
    Oluyomi AO; Gibson EL; Barnfield AM; Curzon G
    Eur J Pharmacol; 1994 Oct; 264(1):111-5. PubMed ID: 7828639
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effects of the l isomer of fenfluramine on dopamine mechanisms in rat brain: further studies.
    Invernizzi R; Bertorelli R; Consolo S; Garattini S; Samanin R
    Eur J Pharmacol; 1989 May; 164(2):241-8. PubMed ID: 2759175
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparison of the effects of fenfluramine and other anorectic agents in different feeding and drinking paradigms in rats.
    Rowland NE; Antelman SM; Bartness TJ
    Life Sci; 1985 Jun; 36(24):2295-300. PubMed ID: 4010458
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Proceedings: The relationship between fenfluramine and norfenfluramine blood levels and anoretic activity in the rat.
    Blundell JE; Campbell DB
    Br J Pharmacol; 1975 Oct; 55(2):261P. PubMed ID: 1201401
    [No Abstract]   [Full Text] [Related]  

  • 28. Influence of fenfluramine and norfenfluramine stereoisomers on the firing rate of central monoaminergic neurons in the rat.
    Scuvée-Moreau J; Dresse A
    Eur J Pharmacol; 1990 Apr; 179(1-2):211-5. PubMed ID: 2364982
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Evidence that hypophagia induced by d-fenfluramine and d-norfenfluramine in the rat is mediated by 5-HT2C receptors.
    Vickers SP; Dourish CT; Kennett GA
    Neuropharmacology; 2001 Aug; 41(2):200-9. PubMed ID: 11489456
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effect of norfenfluramine and two structural analogues on brain 5-hydroxyindoles and serum prolactin in rats.
    Fuller RW; Snoddy HD; Clemens JA; Molloy BB
    J Pharm Pharmacol; 1982 Jul; 34(7):449-50. PubMed ID: 6181246
    [No Abstract]   [Full Text] [Related]  

  • 31. Effects of fenfluramine and norfenfluramine on brain serotonin metabolism in rats.
    Fuller RW; Snoddy HD; Hemrick SK
    Proc Soc Exp Biol Med; 1978 Feb; 157(2):202-5. PubMed ID: 622385
    [No Abstract]   [Full Text] [Related]  

  • 32. The fenfluramine metabolite (+)-norfenfluramine is vasoactive.
    Ni W; Li MW; Thakali K; Fink GD; Watts SW
    J Pharmacol Exp Ther; 2004 May; 309(2):845-52. PubMed ID: 14752059
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Serotonergic mediation of tetrahydro-beta-carboline.
    Schechter MD
    Pharmacol Biochem Behav; 1986 May; 24(5):1209-13. PubMed ID: 3725827
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Discriminative stimulus effects of S(-)-methcathinone (CAT): a potent stimulant drug of abuse.
    Young R; Glennon RA
    Psychopharmacology (Berl); 1998 Dec; 140(3):250-6. PubMed ID: 9877004
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effect of fenfluramine and nicotine upon a stimulant-depressant continuum.
    Schechter MD
    Pharmacol Biochem Behav; 1981 Sep; 15(3):371-5. PubMed ID: 7291239
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparative activity of the enantiomers of fenfluramine and norfenfluramine in rodent seizure models, and relationship with their concentrations in plasma and brain.
    Erenburg N; Hamed R; Shaul C; Perucca E; Bialer M
    Epilepsia; 2023 Jun; 64(6):1673-1683. PubMed ID: 36995363
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Fenfluramine and norfenfluramine on glucose uptake into skeletal muscle.
    Kirby MJ; Turner P
    Postgrad Med J; 1975; 51 Suppl 1():73-6. PubMed ID: 1219683
    [No Abstract]   [Full Text] [Related]  

  • 38. D-Fenfluramine and D-norfenfluramine reduce food intake by acting on different serotonin mechanisms in the rat brain.
    Borsini F; Bendotti C; Aleotti A; Samanin R; Garattini S
    Pharmacol Res Commun; 1982 Jul; 14(7):671-8. PubMed ID: 6215652
    [No Abstract]   [Full Text] [Related]  

  • 39. Discriminative stimulus properties of the serotonin agonist 1-(3-trifluoromethylphenyl)piperazine (TFMPP).
    Glennon RA; McKenney JD; Young R
    Life Sci; 1984 Oct; 35(14):1475-80. PubMed ID: 6482668
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Discriminative stimulus properties of clenbuterol: evidence for beta adrenergic involvement.
    McElroy JF; O'Donnell JM
    J Pharmacol Exp Ther; 1988 Apr; 245(1):155-63. PubMed ID: 2834535
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.